Emerging Dog Vaccines Market Trends: Introduction Of Mucosal-Protected Oral Vaccine Revolutionizes Canine Immunization Technology Shaping the Future of the Industry

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

Dog Vaccines Market Size Growth Forecast: What to Expect by 2025?
In recent years, the market size for dog vaccines has seen substantial growth. Projected growth from $3.61 billion in 2024 to $3.81 billion in 2025 indicates a compound annual growth rate (CAGR) of 5.5%. Factors contributing to this growth during the historical period can be attributed to the innovation of vaccination protocols, awareness of zoonotic diseases, the impact of globalization and travel, educational initiatives, vaccine research and development, as well as the evolution of veterinary practices.

How Will the Dog Vaccines Market Size Evolve and Grow by 2029?
The market for dog vaccines is anticipated to witness significant expansion in the coming years, reaching a value of $5.08 billion in 2029, with a compound annual growth rate (CAGR) of 7.5%. The growth predicted during the forecast period can be ascribed to various factors such as escalating pet adoption rates, burgeoning awareness about pet health among pet owners, stringent government regulations and policies, the increase in viewing pets as family members, and the widespread prevalence of diseases in dogs. In the forthcoming period, the primary trends to watch out for include pet insurance and healthcare schemes, improved availability and access, personalized vaccination approaches, alterations in disease patterns, as well as the invention of new vaccines.

View the full report here:
https://www.thebusinessresearchcompany.com/report/dog-vaccines-global-market-report

What Drivers Are Propelling the Growth of Dog Vaccines Market Forward?
The increasing trend of adopting pet dogs is anticipated to fuel the progress of the dog vaccines market. The term 'pet dog' implies a domesticated or tamed animal that shares a home with people. A dog vaccine is a series of injections administered to dogs, beginning in puppyhood and extending into their adult years. These vaccines invigorate the immune system, enabling dogs to engage with microorganisms without falling ill or, at least, experiencing milder symptoms. For example, the National Pet Owners Survey conducted by the American Pet Products Association, a non-profit organization based in the U.S., revealed that 70% of U.S. homes, equating to about 90.5 million households, owned a pet in 2021-2022. Of this number, around 69 million households maintained a dog as a pet, surpassing the number who kept other animals as pets. Consequently, this increase in pet dog adoption is boosting the dog vaccines market's expansion.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8443&type=smp

Which Emerging Trends Are Transforming the Dog Vaccines Market in 2025?
The rise in technology is a significant trend that's becoming popular in the market for dog vaccines. Major businesses in this market are progressing towards the use of innovative technology for the creation of vaccines. For instance, Merck Animal Health, a company based in the US that offers veterinary pharmaceuticals, vaccines and technological solutions, introduced Nobivac Intra-Trac Oral BbPi in September 2022. This is the first oral vaccine that provides mucosal protection and allows for easy oral application. It's designed to immunize healthy dogs that are 7 weeks or older from the canine parainfluenza virus and Bordetella bronchiseptica. Furthermore, it makes use of an advanced technology known as Immuno-Mist-R technology by Intervet, which is a subsidiary of Merck & Co. This breakthrough technology, named Immuno-Mist-RTM, greatly expands the contact with mucosal surface area.

What Are the Key Segments in the Dog Vaccines Market?
The dog vaccines market covered in this report is segmented -

1) By Type: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, Recombinant Vaccines
2) By Route Of Administration: Subcutaneous, Intramuscular, Intranasal
3) By Application: Below 6 Months, Above 6 Months

Subsegments:
1) By Attenuated Live Vaccines: Canine Parvovirus Vaccine, Canine Distemper Vaccine, Canine Adenovirus Vaccine
2) By Conjugate Vaccines: Canine Leptospira Vaccine, Canine Bordetella Vaccine
3) By Inactivated Vaccines: Canine Parvovirus Vaccine, Canine Influenza Vaccine
4) By Subunit Vaccines: Canine Lyme Disease Vaccine, Canine Parainfluenza Vaccine
5) By Toxoid Vaccines: Canine Leptospirosis Toxoid Vaccine
6) By DNA Vaccines: Canine Melanoma Vaccine
7) By Recombinant Vaccines: Canine Lyme Disease Recombinant Vaccine, Canine Bordetella Recombinant Vaccine

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=8443&type=smp

Who Are the Key Players Shaping the Dog Vaccines Market's Competitive Landscape?
Major companies operating in the dog vaccines market are Vetoquinol S.A., Boehringer Ingelheim GmbH, Ceva Sante Animale, Heska Corporation, Merck & Co. Inc., Virbac Animal Health Pvt. Ltd., Elanco Animal Health Incorporated, Zoetis Inc., CZ Vaccines, Indian Immunologicals Ltd., Meiji Holdings Co. Ltd., Bioveta A.S., Phibro Animal Health Corporation, Hester Biosciences Limited, High Speed Digieal Processor Architecture Pvt. Ltd., Dechra Pharmaceuticals PLC, Norbrook Inc., Biogenesis Bago SA, Vaxxinova India Private Limited, Bimeda Animal Health Ltd., Lohmann Animal Health GmbH, Biovac Ltd., Zenex Animal Health India Pvt. Ltd., Instituto Rosenbusch S A

What Geographic Markets Are Powering Growth in the Dog Vaccines Market?
Asia-Pacific was the largest region in the dog vaccines market in 2024. The regions covered in the dog vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8443

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.